Connect with us

JV Editorial

The Lies Behind Justice Ginsburg’s “Cancer Free” Diagnosis

Published

on

In reports that circulated several days ago regarding the health status of Supreme Court Justice Ruth Bader Ginsburg, one is expected to believe the veracity of the information put forth by the media outlets who disseminated this highly questionable report. According to reports, on January 11th, Supreme Court spokesperson Kathleen Arberg addressed the lung cancer surgery that Justice Ginsburg recently underwent. Arberg announced that Justice Ginsburg had “beaten cancer once again after surgery for two malignant lymph nodes last month. Her recovery from surgery is on track.” She added that “post-surgery evaluation indicates no evidence of remaining disease, and no further treatment in required.” After falling and breaking three ribs, Justice Ginsburg’s doctors discovered cancerous nodes in her lungs.

In reports that circulated several days ago regarding the health status of Supreme Court Justice Ruth Bader Ginsburg, one is expected to believe the veracity of the information put forth by the media outlets who disseminated this highly questionable report. Photo Credit: Shutterstock

Isn’t that interesting? Just fresh out of surgery without the pathology reports available from reputable doctors and such an unsubstantiated diagnosis has been made?

Yes, Judge Ginsburg has beaten cancer in the past, but a cancer determination does not just disappear. Rather it goes into remission; if one is fortunate enough. Thus far, no doctors who treated Justice Ginsburg have corroborated this statement and the simple reason for that is that it is medically untenable and highly irresponsible for any physician to make such an unverified statement at this time.

Seems like political bias has infected this story as well. For liberal Democrats, Ginsburg is the person on the bench that they have pinned their last remaining hope to. Having her vacate her seat on the court at this juncture in time would be tantamount to a whirling dervish of a nightmare for them. So, in order to cool the jets of the overly anxious GOP, (who, the Dems erroneously believe are already beginning a vetting and selection process for Ginsburg’s replacement), they are telling the world to rest assured that Justice Ginsburg will be back in court just as soon as possible.

Politics has no limit on the extent to which hyperbole or alternative facts will be used.

On another entirely separate matter, in order to gain clarity, one must cast a vigilant eye on the medical establishment and those physicians who were treating Justice Ginsburg. Yet another disturbing angle to this story has emerged.

For those who are of the belief that the doctors who attended to Justice Ginsburg at NYC’s Memorial Sloan Kettering Hospital have confirmed that she is cancer free yet have remained silent due to patient privacy laws, let’s take another look.

Just who are these doctors at Sloan Kettering? Several months ago a chief oncologist at Sloan named Dr. Jose Baselga, resigned in disgrace after it was revealed that he was taking huge monetary kick backs from mega pharmaceutical companies. It was recently announced that Dr. Baselga (now out of a job at Sloan) is currently in the employ of AstraZeneca, the Swiss based drug company.

In the dozens of articles that Dr. Baselga penned for such prestigious publications as The New England Journal of Medicine and The Lancet, he had omitted that he was accepting payments from various drug and health care companies.

Dr. Baselga came to Memorial Sloan Kettering in 2013 after serving as chief of hematology and oncology at Massachusetts General Hospital in Boston. Before that he was a leader at the Vall d’Hebron Institute of Oncology in Barcelona, Spain.

Moreover, Dr. Baselga has served in an advisory capacity with such pharmaceutical companies at Roche and Bristol-Myers Squibb, among other drug companies. Dr. Baselga also resigned from the board of Bristol-Myers Squibb, which he had served on since March of 2018.

Since 2014, Dr. Baselga has received $3 million in consulting fees from Roche.

The egregious findings really rocked Sloan Kettering to the core. The hospital’s leading executives made a feverish effort to tamp down the negative impact of such revelations on the institution’s reputation for medical excellence.

Well, this distressing news compels us to shine some sunlight on the state of affairs of our medical profession. We must take stock and ask ourselves, ”how many other doctors who manage and ostensibly treat patients with life threatening illnesses are also on the payroll of Big Pharma? How many doctors that we trust are in reality just executing the agenda of their handlers when dispensing meds to patients?”

Sure, there are always medical “quacks” out there roaming the planet, but in this instance we are talking about the premiere medical institution in North America that has earned a reputation for its commitment to treating cancer and other related diseases. We expect better, a lot better from the doctors that we entrust our lives and the lives of our loved ones to.

Is Sloan Kettering ready to step up to plate and ensure the public that patient treatment is not tainted by bribes?

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Advertisement
Advertisement --

Trending

Daily Newsletter

Get all the breaking news delivered right to your inbox as it happens

Sign Up Now!